RT Journal Article
SR Electronic
T1 Acute pulmonary embolism
JF Clinical Medicine
JO Clin Med
FD Royal College of Physicians
SP 243
OP 247
DO 10.7861/clinmedicine.19-3-247
VO 19
IS 3
A1 Luke Howard
YR 2019
UL http://www.rcpjournals.org/content/19/3/243.abstract
AB Pulmonary embolism, despite being common, often remains elusive as a diagnosis, and clinical suspicion needs to remain high when seeing a patient with cardiopulmonary symptoms. Once suspected, diagnosis is usually straightforward; however, optimal treatment can be difficult. Risk stratification with clinical scores, biomarkers and imaging helps to refine the best treatment strategy, but the position of thrombolysis in intermediate risk (submassive) pulmonary embolism remains a grey area. Pulmonary embolism response teams are on the increase to provide advice in such cases. Direct oral anticoagulants have been a major advance in treatment this decade, but are not appropriate for all patients. Follow-up of patients with pulmonary embolism should be mandatory to determine duration of anticoagulation and to assess for serious long-term complications.